|
|
|
|
|
|
[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
Valenzuela P.,
Quiroga M.,
Zaldivar J.,
Gray P.,
Rutter W.J.;
"The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes.";
(In) Field B.N., Jaenisch R., Fox C.F. (eds.); Animal virus genetics, pp.57-70, Academic Press, New York (1980).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 315-611.
DOI=10.1038/280815a0; PubMed=471053 [NCBI, ExPASy, EBI, Israel, Japan]
Valenzuela P.,
Gray P.,
Quiroga M.,
Zaldivar J.,
Goodman H.M.,
Rutter W.J.;
"Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen.";
Nature 280:815-819(1979).
|
[3]
|
INHIBITION BY LAMIVUDINE.
DOI=10.1002/1096-9071(200007)61:3<367::AID-JMV15>3.0.CO;2-A; PubMed=10861648 [NCBI, ExPASy, EBI, Israel, Japan]
Lai C.L.,
Yuen M.F.;
"Profound suppression of hepatitis B virus replication with lamivudine.";
J. Med. Virol. 61:367-373(2000).
|
[4]
|
INHIBITION BY ADEFOVIR.
DOI=10.1586/14787210.2.4.475; PubMed=15482214 [NCBI, ExPASy, EBI, Israel, Japan]
Hadziyannis S.J.,
Papatheodoridis G.V.;
"Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.";
Expert Rev. Anti Infect. Ther. 2:475-483(2004).
|
[5]
|
INHIBITION BY ENTECAVIR.
DOI=10.1128/JVI.02395-06; PubMed=17267485 [NCBI, ExPASy, EBI, Israel, Japan]
Langley D.R.,
Walsh A.W.,
Baldick C.J.,
Eggers B.J.,
Rose R.E.,
Levine S.M.,
Kapur A.J.,
Colonno R.J.,
Tenney D.J.;
"Inhibition of hepatitis B virus polymerase by entecavir.";
J. Virol. 81:3992-4001(2007).
|
[6]
|
REVIEW.
PubMed=17206754 [NCBI, ExPASy, EBI, Israel, Japan]
Beck J.,
Nassal M.;
"Hepatitis B virus replication.";
World J. Gastroenterol. 13:48-64(2007).
|
|
|
|
- FUNCTION: Multifunctional enzyme that converts the viral RNA genome into dsDNA in viral cytoplasmic capsids. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3'- to 5'-endonucleasic mode. Neo-synthesized pregenomic RNA (pgRNA) are encapsidated together with the P protein, and reverse-transcribed inside the nucleocapsid. Initiation of reverse-transcription occurs first by binding the epsilon loop on the pgRNA genome, and is initiated by protein priming, thereby the 5'-end of (-)DNA is covalently linked to P protein. Partial (+)DNA is synthesized from the (-)DNA template and generates the relaxed circular DNA (RC-DNA) genome. After budding and infection, the RC-DNA migrates in the nucleus, and is converted into a plasmid-like covalently closed circular DNA (cccDNA). The activity of P protein does not seem to be necessary for cccDNA generation, and is presumably released from (+)DNA by host nuclear DNA repair machinery.
- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).
- CATALYTIC ACTIVITY: Endonucleolytic cleavage to 5'-phosphomonoester.
- ENZYME REGULATION: Activated by host HSP70 and HSP40 in vitro to be able to bind the epsilon loop of the pgRNA. Because deletion of the RNase H region renders the protein partly chaperone-independent, the chaperones may be needed indirectly to releive occlusion of the RNA-binding site by this domain (By similarity). Inhibited by several reverse-transcriptase inhibitors: Lamivudine, Adefovir and Entecavir.
- DOMAIN: Terminal protein domain (TP) is hepadnavirus-specific. Spacer domain is highly variable and separates the TP and RT domains. Polymerase/reverse-transcriptase domain (RT) and ribonuclease H domain (RH) are similar to retrovirus reverse transcriptase/RNase H.
- DOMAIN: The polymerase/reverse transcriptase (RT) and ribonuclease H (RH) domains are structured in five subdomains: finger, palm, thumb, connection and RNase H. Within the palm subdomain, the 'primer grip' region is thought to be involved in the positioning of the primer terminus for accommodating the incoming nucleotide. The RH domain stabilizes the association of RT with primer-template.
- MISCELLANEOUS: Hepadnaviral virions contain probably just one P protein molecule per particle.
- SIMILARITY: Belongs to the hepadnaviridae P protein family.
- SIMILARITY: Contains 1 reverse transcriptase domain.
- WEB RESOURCE: Name=HepSEQ; Note=Hepatitis virus B database; URL="http://www.hpa-bioinfodatabases.org.uk/hepatitis_open/main.php";.
|
|
|
|
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms.
Distributed under the Creative Commons Attribution-NoDerivs License.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Length: 845 AA [This is the length of the unprocessed precursor] |
Molecular weight: 94800 Da [This is the MW of the unprocessed precursor] |
CRC64: 68A09F4783463D98 [This is a checksum on the sequence] |
|
10 20 30 40 50 60
MPLSYQHFRK LLLLDDGTEA GPLEEELPRL ADADLHRRVA EDLNLGNLNV SIPWTHKVGN
70 80 90 100 110 120
FTGLYSSTVP IFNPEWQTPS FPKIHLQEDI INRCQQFVGP LTVNEKRRLK LIMPARFYPT
130 140 150 160 170 180
HTKYLPLDKG IKPYYPDQVV NHYFQTRHYL HTLWKAGILY KRETTRSASF CGSPYSWEQE
190 200 210 220 230 240
LQHGRLVIKT SQRHGDESFC SQSSGILSRS SVGPCIRSQL KQSRLGLQPR QGRLASSQPS
250 260 270 280 290 300
RSGSIRAKAH PSTRRYFGVE PSGSGHIDHS VNNSSSCLHQ SAVRKAAYSH LSTSKRQSSS
310 320 330 340 350 360
GHAVEFHCLP PNSAGSQSQG SVSSCWWLQF RNSKPCSEYC LSHLVNLRED WGPCDEHGEH
370 380 390 400 410 420
HIRIPRTPAR VTGGVFLVDK NPHNTAESRL VVDFSQFSRG ISRVSWPKFA VPNLQSLTNL
430 440 450 460 470 480
LSSNLSWLSL DVSAAFYHIP LHPAAMPHLL IGSSGLSRYV ARLSSNSRIN NNQYGTMQNL
490 500 510 520 530 540
HDSCSRQLYV SLMLLYKTYG WKLHLYSHPI VLGFRKIPMG VGLSPFLLAQ FTSAICSVVR
550 560 570 580 590 600
RAFPHCLAFS YMDDVVLGAK SVQHRESLYT AVTNFLLSLG IHLNPNKTKR WGYSLNFMGY
610 620 630 640 650 660
IIGSWGTLPQ DHIVQKIKHC FRKLPVNRPI DWKVCQRIVG LLGFAAPFTQ CGYPALMPLY
670 680 690 700 710 720
ACIQAKQAFT FSPTYKAFLS KQYMNLYPVA RQRPGLCQVF ADATPTGWGL AIGHQRMRGT
730 740 750 760 770 780
FVAPLPIHTA ELLAACFARS RSGAKLIGTD NSVVLSRKYT SFPWLLGCTA NWILRGTSFV
790 800 810 820 830 840
YVPSALNPAD DPSRGRLGLS RPLLRLPFQP TTGRTSLYAV SPSVPSHLPV RVHFASPLHV
AWRPP
|
P03159 in FASTA format |
|
ExPASy Home page
SIB Switzerland
